| |
| |
|
| Insider
Information: |
Gullans Steven R. Ph.d. |
| Relationship: |
Director |
| City: |
Boston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
328,250 |
|
|
Indirect Shares
|
2,398,757 |
|
|
| Direct
Value |
$95,900 |
|
|
|
Indirect Value
|
$625,643 |
|
|
| Total
Shares |
2,727,007 |
|
|
| Total
Value |
$721,543 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Tetraphase Pharmaceuticals Inc |
TTPH |
Director |
2014-05-19 |
25,000 |
2014-05-19 |
1,468,505 |
Premium* |
|
|
NeuroBo Pharmaceuticals Inc |
NRBO |
Interim President & CE... |
2019-07-24 |
300,000 |
2018-02-08 |
930,252 |
Premium* |
|
|
Ispecimen Inc. |
ISPC |
Director |
2023-01-01 |
3,250 |
2023-01-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
9 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ISPC |
Ispecimen Inc. |
Director |
– • – |
2023-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
125 |
3,250 |
0 |
- |
|
| NRBO |
NeuroBo Pharmaceuticals I... |
President & CEO |
• • – |
2019-07-24 |
4 |
A |
$0.00 |
$0 |
D/D |
300,000 |
300,000 |
0 |
- |
|
| NRBO |
NeuroBo Pharmaceuticals I... |
Interim President & CEO |
• • – |
2018-02-08 |
4 |
B |
$7.00 |
$500,003 |
I/I |
71,429 |
930,252 |
2.66 |
- |
|
| NRBO |
NeuroBo Pharmaceuticals I... |
Director |
– • – |
2017-03-10 |
4 |
B |
$9.47 |
$499,997 |
I/I |
52,798 |
858,823 |
2.1 |
- |
|
| NRBO |
NeuroBo Pharmaceuticals I... |
Director |
– • – |
2016-08-10 |
4 |
OE |
$6.71 |
$2,052,173 |
I/I |
306,025 |
306,025 |
0 |
- |
|
| NRBO |
NeuroBo Pharmaceuticals I... |
Director |
– • – |
2016-08-10 |
4 |
B |
$10.00 |
$5,000,000 |
I/I |
500,000 |
806,025 |
2.1 |
- |
|
| TTPH |
Tetraphase Pharmaceutical... |
Director |
– • – |
2014-05-19 |
4 |
B |
$9.24 |
$230,978 |
D/D |
25,000 |
25,000 |
2.39 |
- |
|
| TTPH |
Tetraphase Pharmaceutical... |
Director |
– • • |
2013-03-25 |
4 |
A |
$0.00 |
$0 |
I/I |
972,384 |
972,384 |
0 |
- |
|
| TTPH |
Tetraphase Pharmaceutical... |
Director |
– • • |
2013-03-25 |
4 |
B |
$7.00 |
$3,472,847 |
I/I |
496,121 |
1,468,505 |
2.25 |
- |
|
9 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
